Targeting and functional effects of biomaterials-based nanoagents for acute pancreatitis treatment
- PMID: 36704304
- PMCID: PMC9871307
- DOI: 10.3389/fbioe.2022.1122619
Targeting and functional effects of biomaterials-based nanoagents for acute pancreatitis treatment
Abstract
Acute pancreatitis (AP) is a severe life-threatening inflammatory disease showing primary characteristics of excessive inflammatory response and oxidative stress. Based on the pathophysiology of AP, several anti-inflammatory and anti-oxidative stress agents have been studied. However, the low accumulated concentrations and scattered biodistributions limit the application of these agents. With the development of nanotechnology, functional nanomaterials can improve the bioavailability of drugs and extend their half-life by reducing immunogenicity to achieve targeted drug delivery. The biomaterial-based carriers can mediate the passive or active delivery of drugs to the target site for improved therapeutic effects, such as anti-oxidation and anti-inflammation for AP treatment. Other biomaterials-based nanomedicine may exhibit different functions with/without targeting effects. In this review, we have summarized the targeting and functional effects of biomaterials-based nanoagents specifically for AP treatment.
Keywords: active targeting; acute pancreatitis; biomaterials; nanotechnology; passive targeting.
Copyright © 2023 Cai, Cao, Li and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer XW declared a shared parent affiliation with the authors to the handling editor at the time of review.
Figures
Similar articles
-
From micro to macro, nanotechnology demystifies acute pancreatitis: a new generation of treatment options emerges.J Nanobiotechnology. 2025 Jan 29;23(1):57. doi: 10.1186/s12951-025-03106-6. J Nanobiotechnology. 2025. PMID: 39881355 Free PMC article. Review.
-
Microenvironment of pancreatic inflammation: calling for nanotechnology for diagnosis and treatment.J Nanobiotechnology. 2023 Nov 23;21(1):443. doi: 10.1186/s12951-023-02200-x. J Nanobiotechnology. 2023. PMID: 37996911 Free PMC article. Review.
-
Protective effects and mechanisms of bilirubin nanomedicine against acute pancreatitis.J Control Release. 2020 Jun 10;322:312-325. doi: 10.1016/j.jconrel.2020.03.034. Epub 2020 Apr 1. J Control Release. 2020. PMID: 32243974
-
Research Progress of Antioxidant Nanomaterials for Acute Pancreatitis.Molecules. 2022 Oct 25;27(21):7238. doi: 10.3390/molecules27217238. Molecules. 2022. PMID: 36364064 Free PMC article. Review.
-
Ultrasound-induced destruction of heparin-loaded microbubbles attenuates L-arginine-induced acute pancreatitis.Eur J Pharm Sci. 2023 Jan 1;180:106318. doi: 10.1016/j.ejps.2022.106318. Epub 2022 Nov 1. Eur J Pharm Sci. 2023. PMID: 36332825
Cited by
-
Natural Compounds for the Treatment of Acute Pancreatitis: Novel Anti-Inflammatory Therapies.Biomolecules. 2024 Sep 2;14(9):1101. doi: 10.3390/biom14091101. Biomolecules. 2024. PMID: 39334867 Free PMC article. Review.
-
Effects of Oxidative Stress on Serum Metabolism in Acute Pancreatitis Rats Based on Untargeted Metabolomics.Comb Chem High Throughput Screen. 2025;28(10):1679-1693. doi: 10.2174/0113862073291605240525144749. Comb Chem High Throughput Screen. 2025. PMID: 38920067
References
-
- Anchi P., Khurana A., Swain D., Samanthula G., Godugu C. (2018). Sustained-release curcumin microparticles for effective prophylactic treatment of exocrine dysfunction of pancreas: A preclinical study on cerulein-induced acute pancreatitis. J. Pharm. Sci. 107 (11), 2869–2882. 10.1016/j.xphs.2018.07.009 - DOI - PubMed
-
- Atiyah N. A., Albayati T. M., Atiya M. A. (2022). Interaction behavior of curcumin encapsulated onto functionalized sba-15 as an efficient carrier and release in drug delivery. J. Mol. Struct. 1260, 132879. 10.1016/j.molstruc.2022.132879 - DOI
Publication types
LinkOut - more resources
Full Text Sources